Inflammatory Bowel Disease: Diagnosis and TreatmentGary L. Gitnick |
From inside the book
Results 1-3 of 84
Page 47
... factors Bacteria PAF Cytotoxic factors Lymphocyte Release of HO 22 Factors Monocyte PMN Protein Lymphocyte 3 Recruitment of Neutrophils and Monocytes Uncontrolled Immune Response to Antigen Fig . 6.3 Nonspecific " innocent bystander ...
... factors Bacteria PAF Cytotoxic factors Lymphocyte Release of HO 22 Factors Monocyte PMN Protein Lymphocyte 3 Recruitment of Neutrophils and Monocytes Uncontrolled Immune Response to Antigen Fig . 6.3 Nonspecific " innocent bystander ...
Page 73
... factors . The two principal lines of evidence for the involvement of environmental factors are geographic differences and temporal changes in IBD frequency . Even if environmental factors are involved , they may be so ubiqui- tous that ...
... factors . The two principal lines of evidence for the involvement of environmental factors are geographic differences and temporal changes in IBD frequency . Even if environmental factors are involved , they may be so ubiqui- tous that ...
Page 255
... Factors for Bone Loss Several factors are probably responsible for bone loss in patients with inflam- matory bowel disease ( Table 17.4 ) ; steroid therapy is one important factor and some women with severe disease undergo a premature ...
... Factors for Bone Loss Several factors are probably responsible for bone loss in patients with inflam- matory bowel disease ( Table 17.4 ) ; steroid therapy is one important factor and some women with severe disease undergo a premature ...
Contents
Approaches to Management | 3 |
Epidemiology | 23 |
Where Have We Been? Where Are We Going? | 29 |
Copyright | |
32 other sections not shown
Other editions - View all
Common terms and phrases
5-aminosalicylic acid abdominal abnormalities abscess acute anal anastomosis ankylosing spondylitis antibiotics antigens arthritis associated azathioprine barium biopsies cancer carcinoma cells chronic clinical colectomy colitis and Crohn's colon colonoscopy complications controlled trial corticosteroids Crohn's colitis Crohn's disease diagnosis diarrhea diet dilatation disease activity disease and ulcerative distal dosage dose drug dysplasia endoscopic enemas epithelial evaluation factors fistulas Gastroenterology genetic histologic hydrocortisone IBD patients ileal ileoanal ileostomy ileum immunosuppressive improved increased inflammation inflammatory bowel disease intestinal intravenous involvement Lancet Lennard-Jones lesions manifestations methotrexate metronidazole mucosa normal obstruction occur oral parenteral nutrition patients with Crohn's patients with ulcerative perianal physician placebo pouch procedure prednisolone prednisone present proctitis prognosis rectal rectum recurrence relapse remission reported resection response risk serum side effects sigmoidoscopic small bowel steroids stool strictures sulfasalazine Surg surgery surgical symptoms therapeutic therapy tion tissue toxic megacolon treated Truelove ulcerative colitis usually